These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22204557)

  • 1. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
    Gisslén M; Price RW; Nilsson S
    BMC Infect Dis; 2011 Dec; 11():356. PubMed ID: 22204557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
    Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
    PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
    Nyundo AA
    PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary trends in HIV-associated neurocognitive disorders in Ghana.
    Sarfo FS; Kyem G; Asibey SO; Tagge R; Ovbiagele B
    Clin Neurol Neurosurg; 2021 Nov; 210():107003. PubMed ID: 34715557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.
    Su T; Schouten J; Geurtsen GJ; Wit FW; Stolte IG; Prins M; Portegies P; Caan MW; Reiss P; Majoie CB; Schmand BA;
    AIDS; 2015 Mar; 29(5):547-57. PubMed ID: 25587908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Frailty and HIV-Associated Neurodegenerative Disorders Among Older Adults Living with HIV.
    Zamudio-Rodríguez A; Belaunzarán-Zamudio PF; Sierra-Madero JG; Cuellar-Rodríguez J; Crabtree-Ramírez BE; Alcala-Zermeno JL; Amieva H; Avila-Funes JA
    AIDS Res Hum Retroviruses; 2018 May; 34(5):449-455. PubMed ID: 29385834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
    Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
    Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period.
    Rourke SB; Bekele T; Rachlis A; Kovacs C; Brunetta J; Gill MJ; Carvalhal A; Cysique LA; Marcotte T; Power C
    AIDS; 2021 Jan; 35(1):63-72. PubMed ID: 33048883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis.
    Wang Y; Liu M; Lu Q; Farrell M; Lappin JM; Shi J; Lu L; Bao Y
    Neurology; 2020 Nov; 95(19):e2610-e2621. PubMed ID: 32887786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological soft signs as a marker of cognitive impairment severity in people living with HIV.
    Toro P; Ceballos ME; Pesenti J; Inostroza M; Valenzuela D; Henríquez F; Forno G; Herold C; Schröder J; Calderón J
    Psychiatry Res; 2018 Aug; 266():138-142. PubMed ID: 29870954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-Associated Dementia: Associated Factors and Characteristics of Cognitive Domain Abnormalities in Elderly People Living with HIV Treated with Highly Active Antiretroviral Therapy.
    Boonyagars L; Kiatsoongsong N; Winitprichagul S
    Am J Trop Med Hyg; 2022 Dec; 107(6):1250-1257. PubMed ID: 36315995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV, aging, and cognition: emerging issues.
    Valcour VG
    Top Antivir Med; 2013; 21(3):119-23. PubMed ID: 23981600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
    Vassallo M; Fabre R; Durant J; Lebrun-Frenay C; Joly H; Ticchioni M; DeSalvador F; Harvey-Langton A; Dunais B; Laffon M; Cottalorda J; Dellamonica P; Pradier C
    J Neurovirol; 2017 Apr; 23(2):216-225. PubMed ID: 27815816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive disorders in HIV-infected patients: are they HIV-related?
    Bonnet F; Amieva H; Marquant F; Bernard C; Bruyand M; Dauchy FA; Mercié P; Greib C; Richert L; Neau D; Catheline G; Dehail P; Dabis F; Morlat P; Dartigues JF; Chêne G;
    AIDS; 2013 Jan; 27(3):391-400. PubMed ID: 23079813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research.
    Cysique LA; Heaton RK; Kamminga J; Lane T; Gates TM; Moore DM; Hubner E; Carr A; Brew BJ
    J Neurovirol; 2014 Jun; 20(3):258-68. PubMed ID: 24696363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders.
    Cherner M; Cysique L; Heaton RK; Marcotte TD; Ellis RJ; Masliah E; Grant I;
    J Neurovirol; 2007; 13(1):23-8. PubMed ID: 17454445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power.
    Meyer AC; Boscardin WJ; Kwasa JK; Price RW
    Neuroepidemiology; 2013; 41(3-4):208-16. PubMed ID: 24157541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.